IPHA Annual Meeting 2010
ENTERPRISE AND HEALTH SOLUTIONS FOR IRISH PATIENTS AND THE IRISH ECONOMY Aviva Stadium, 25th November 2010
Supporting Irish patients and the Irish economy
THE PHARMACEUTICAL SECTOR GENERATES 58 PERCENT OF THE COUNTRY’S EXPORTS WHICH CONTRIBUTES TO MAKING IRELAND THE SECOND LARGEST NET EXPORTER OF MEDICINES IN THE WORLD. THE PHARMACEUTICAL SECTOR DIRECTLY EMPLOYS OVER 24,500 PEOPLE, OVER HALF OF WHICH ARE THIRD LEVEL GRADUATES.
Agenda
9.00 am
Mr David Gallagher, President, IPHA Welcome address to the 17th IPHA Annual Meeting
9.10 am
Mr Bryan Dobson, Anchor with RTÉ Six One News Introduction and agenda summary
Session 1: Securing the future of the international research-based pharmaceutical industry in Ireland 9.15 am
Mr Barry O’Leary, Chief Executive, IDA Ireland The IDA Ireland strategy for the pharmaceutical industry in Ireland
9.30 am
Dr Ruth Barrington, Director, Molecular Medicine Ireland The role of clinical research in securing the future of the industry in Ireland
9.45 am
Mr Pat O’Mahony, Irish Medicines Board The contribution of a world-class regulatory environment to the future of the industry in Ireland Q&A
MEDICINES HAVE HELPED TO IMPROVE LIFE EXPECTANCY IN IRELAND BY OVER A THIRD IN THE LAST SEVENTY YEARS, FROM 57 IN 1925 TO 79 TODAY. THE USE OF MEDICINES HAS CONTRIBUTED TO REDUCING THE NUMBER OF DEATHS FROM HEART DISEASE AND STROKE BY NEARLY A HALF.
THE USE OF MEDICINES HAS HELPED THOUSANDS OF IRISH PATIENTS WITH PARKINSON’S, ALZHEIMER’S, ULCERS, CANCER, DIABETES AND MENTAL ILLNESS TO LEAD BETTER AND MORE NORMAL LIVES, EASING THE BURDEN ON CARE-GIVERS AND DELAYING OR AVOIDING COSTLY LONG-TERM NURSING CARE.
Session 2: Panel discussion – How to ensure the best utilisation of healthcare resources (facilitated by Mr Bryan Dobson) 10.30 am
Prof Frances Ruane, Chairperson of the Expert Group on Resource Allocation in the Health Sector, Executive Director of the ESRI The economist perspective Dr Fergus O'Ferrall, Adelaide Lecturer in Health Policy, Department of Public Health and Primary Care, Trinity College Dublin The universal health insurance advocate perspective Mr Jimmy Tolan, Chief Executive, VHI The health insurance sector perspective Q&A
11.30 am
Coffee/tea break
Session 3 Ensuring the best health outcomes for Irish patients while securing value for money 12.00 pm
Mr David Gallagher, President, IPHA The value of medicines and vaccines to Irish patients
12.15 pm
Dr Michael Barry, Clinical Director, National Centre for Pharmacoeconomics The role of Health Technology Assessment and current developments in Ireland
12.30 pm
Dr Barry White, National Director of Quality and Clinical Care, Health Service Executive The development of national programmes of care, clinical pathways, therapeutic guidelines etc. Q&A
1.00 pm
MEDICINES HAVE HELPED TO ENABLE IRISH HOSPITALS TO TREAT MORE PATIENTS ON A DAY CASE BASIS, FROM 85,000 CASES IN 1987 TO AN ESTIMATED 770,000 IN 2008.
Ms Anne Nolan, Chief Executive, IPHA Summary and close
* Please note that all of the presentations and a podcast of the Annual Meeting will be available on the IPHA website (www.ipha.ie) on Monday, 29th November 2010.
The Irish Pharmaceutical Healthcare Association (IPHA) represents the international research based pharmaceutical industry in Ireland. Our members include both manufacturers of prescription medicines and non-prescription or consumer health care medicines. Today people in Ireland live longer, healthier and more active lives, in part, due to medical progress and the use of new innovative medicines. Not only is the pharmaceutical industry critical to the health of the nation, it plays a critical and substantial role in the Irish economy. Irish Pharmaceutical Healthcare Association Franklin House 140 Pembroke Road Dublin 4 Ireland Tel: (353 1) 660 3350 Fax: (353 1) 668 6672 E-mail: info@ipha.ie www.ipha.ie www.medicines.ie www.feelbetter.ie www.self-care.ie
Follow the IPHA on...